Picture of Calumet logo

CLMT Calumet News Story

0.000.00%
us flag iconLast trade - 00:00
EnergyAdventurousMid CapNeutral

Calumet Specialty Products Partners LP expected to post breakeven results a share - Earnings Preview

* Calumet Specialty Products Partners LP  CLMT.OQ 
 CLMT.O  is
expected to show a rise in quarterly revenue when it reports 
results on March 15. 
    * The Indianapolis Indiana-based  company is expected to
report  a
4.5% increase in revenue to $904.428 million from $865.8 million
a year ago, according to the mean estimate from 4 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Calumet Specialty
Products Partners LP is for breakeven results per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Calumet
Specialty
Products Partners LP is $25​, above​ its last closing price
of $18.12. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  0.63        0.33       0.19      Missed  -42.7
 Jun. 30 2022  0.38        0.22       -0.19     Missed  -185.4
 Mar. 31 2022  -0.53       -0.50      -1.18     Missed  -137​
 Dec. 31 2021  -0.54       -0.39      -1.08     Missed  -175.1
 ​​Sep.        -0.15       -0.15      0.64      Beat    532.4
 30 2021                                                
 Jun. 30 2021  -0.35       -0.48      -0.38     Beat    20.8​
 Mar. 31 2021  -0.62       -0.62      -0.80     Missed  -28
 Dec. 31 2020  -0.79       -0.79      -0.89     Missed  -12.8
 This summary was machine generated March 13 at 13:31 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Calumet

See all news